Fed keeps rates steady as it notes ‘lack of further progress’ on inflation
With the decision to hold the line on rates, the committee noted a “lack of further progress” in getting inflation back down to the central bank’s 2% target.
Here’s what changed in the new Fed statement
This is a comparison of Wednesday’s Federal Open Market Committee statement with the one issued after the Fed’s previous policymaking meeting in March.
The Federal Reserve holds interest rates steady, offers no relief from high borrowing costs — what that means for your money
The Federal Reserve pushed out rate-cut expectations — here’s what that means for your credit card, mortgage rate, auto loan and savings account.
Amazon-backed Anthropic launches iPhone app and business tier to compete with OpenAI’s ChatGPT
Anthropic on Wednesday announced its first-ever enterprise offering, as well as its first iOS app.
Why hundreds of U.S. banks may be at risk of failure
Of about 4,000 banks, 282 banks face threats from commercial real estate and higher interest rates, according to a study by Klaros Group.
Pfizer beats earnings estimates, raises outlook on cost cuts and smaller-than-feared drop in Covid drug sales
The pharmaceutical giant’s quarterly results also benefited from a smaller-than-feared drop in sales for its Covid antiviral pill Paxlovid.
Private payrolls increased by 192,000 in April, more than expected for resilient labor market
Private payrolls increased at a faster than expected pace in April, indicating there are still plenty of tailwinds for the U.S. labor market.
Johnson & Johnson to pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
The deal would allow J&J to resolve the lawsuits through a third bankruptcy filing of a subsidiary company, LTL Management.
Demand for riskier adjustable-rate mortgages hits highest level of the year, due to rising rates
The share of ARM applications rose to 7.8% of mortgage demand last week, according to the Mortgage Bankers Association. That is the highest level of the year.
CVS shares plummet as health company slashes profit outlook on higher medical costs
CVS and other insurers have seen medical costs spike as many Medicare Advantage patients return to hospitals to undergo procedures they delayed during Covid.
